You are here: Industry Insights > FDA nod

News List

Pfizer, Astellas' Xtandi Gets FDA nod biospectrumasia
December 18, 2019
For the treatment of patients with metastatic castration-sensitive prostate cancer
Chasing Pfizer and J&J, Bayer’s Nubeqa nabs fast FDA nod in prostate cancer biospectrumasia
August 01, 2019
Pfizer and Astellas’ Xtandi and Johnson & Johnson’s Erleada may have big head starts in the prostate cancer market, but Bayer and partner Orion have a new entry—and they're looking to carve out a share.
Merck's Keytruda, up for new FDA nod, spurs lengthy responses in small cell lung cancer fiercepharma
April 02, 2019
Merck & Co. is awaiting an FDA decision for Keytruda in previously treated small cell lung cancer, and it has new numbers to boost its case.
Sanofi scores FDA nod for $270K nanobody drug Cablivi, its first from the Ablynx deal fiercepharma
February 24, 2019
Sanofi scooped up nanobody biotech Ablynx last year in a $4.5 billion deal—and now, the buyout may be starting to pay off. Cablivi, an Ablynx nanobody for a rare blood-clotting disorder, has snagged its FDA green light.